Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Patents as collateral for securitization

Nature Biotechnology volume 35, pages 514–516 (2017)Cite this article

Subjects

Patents are important assets for biotech organizations, not only for protecting inventions but also as assets to raise monies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Patents and securitization.
Figure 2

References

  1. Hand, J.R.M. http://ssrn.com/abstract=294471 (December 8, 2001).

  2. Holger Kollmer, H. & Dowling, M. Res. Policy 33, 1141–1151 (2004).

    Article  Google Scholar 

  3. Burrone, E. WIPO http://www.wipo.int/sme/en/documents/patents_biotech_fulltext.html (2006).

    Google Scholar 

  4. Cockburn, I.M. & Wagner, S. NBER Working Paper No. 13146 (2007).

  5. Mann, R.J. & Sager, T.W. Res. Policy 36, 193–208 (2007).

    Article  Google Scholar 

  6. Prevezer, M. Small Bus. Econ. 17, 17–29 (2001).

    Article  Google Scholar 

  7. Kirsh, A. Securitization of Intellectual Property as a Funding Alternative. Master's thesis, HfB Business School of Finance and Management, Frankfurt (2005).

    Google Scholar 

  8. Dorris, M.D. The securitization of drug royalties: a new elixir? Global Securitisation and Structured Finance, Deutsche Bank (2003). https://www.dechert.com/files/Publication/d336b8f7-efac-4ba3-b8e8-a9c0de639077/Presentation/PublicationAttachment/13bef0bc-c9f7-4ed6-af3c-aac915007ac9/Securitization%20of%20Drug%20Royalties_Dorris-2003.pdf

  9. Jobst, A.A. Manag. Finance 32, 731–760 (2006).

    Google Scholar 

  10. Ughetto, E. in Powerful Finance and Innovation Trends in a High-Risk Economy (224–247). Laperche, B. & Uzunidis, D. (eds.); (Palgrave Macmillan UK, 2008).

    Book  Google Scholar 

  11. Watanabe, H. Intellectual Property as securitized assets. The Institute of Intellectual Property Working Paper (March 2004). https://www.iip.or.jp/e/e_summary/pdf/detail2003/e15_20.pdf

  12. Hillery, J.S. Securitization of Intellectual Property: Recent trends from the United States. Washington CORE Working Paper (2004).

    Google Scholar 

  13. Haemmerli, A. Columbia Law Rev. 96, 1645–1752 (1996).

    Article  Google Scholar 

  14. Mills, A.G. Banking L. J. 125, 746 (2008).

    Google Scholar 

  15. 37 CFR 1.27(f) and (g). https://www.law.cornell.edu/cfr/text/37/1.27

Download references

Author information

Authors and Affiliations

  1. Nishad Deshpande is at the CSIR Unit for Research and Development of Information Products and Symbiosis International University, Pune, India,

    Nishad Deshpande

  2. Asha Nagendra is in the Symbiosis Institute of Management Studies, Symbiosis International University, Pune, India.,

    Asha Nagendra

Authors
  1. Nishad Deshpande
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asha Nagendra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nishad Deshpande.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deshpande, N., Nagendra, A. Patents as collateral for securitization. Nat Biotechnol 35, 514–516 (2017). https://doi.org/10.1038/nbt.3891

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3891

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research